An; Ling-Ling

Patent Applications and Registrations

Patent applications and USPTO patent grants for An; Ling-Ling.The latest application filed is for "humanized anti-factor d antibodies and uses thereof".

Company Profile

1.10.16

An; Ling-Ling - Boyds MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized Anti-factor D Antibodies And Uses Thereof App 20170166630 - An; Ling-Ling ; et al.	2017-06-15
Humanized Anti-Factor D Antibodies And Uses Thereof App 20160002353 - An; Ling-Ling ; et al.	2016-01-07
Humanized Anti-Factor D Antibodies And Uses Thereof App 20160002352 - An; Ling-Ling ; et al.	2016-01-07
Humanized Anti-Factor D Antibodies And Uses Thereof App 20150376295 - An; Ling-Ling ; et al.	2015-12-31
Humanized Anti-Factor D Antibodies And Uses Thereof App 20140303355 - An; Ling-Ling ; et al.	2014-10-09
Methods of detecting factor D with anti-factor D antibodies Grant 8,753,826 - An , et al. June 17, 2	2014-06-17
Humanized Anti-Factor D Antibodies And Uses Thereof App 20130171070 - An; Ling-Ling ; et al.	2013-07-04
Humanized anti-factor D antibodies and uses thereof Grant 8,372,403 - An , et al. February 12, 2	2013-02-12
Humanized Anti-factor D Antibodies And Uses Thereof App 20120230985 - AN; LING-LING ; et al.	2012-09-13
Nucleic acids encoding anti-factor D antibodies Grant 8,193,329 - An , et al. June 5, 2	2012-06-05
Methods of treating with anti-factor D antibodies Grant 8,187,604 - An , et al. May 29, 2	2012-05-29
High affinity antibodies against HMGB1 and methods of use thereof Grant 8,153,131 - Wu , et al. April 10, 2	2012-04-10
High affinity antibodies against HMGB1 and methods of use thereof Grant 8,129,130 - Wu , et al. March 6, 2	2012-03-06
Humanized anti-factor D antibodies Grant 8,067,002 - An , et al. November 29, 2	2011-11-29
High Affinity Antibodies Against HMGB1 and Methods of Use Thereof App 20110287023 - Wu; Herren ; et al.	2011-11-24
Humanized Anti-factor D Antibodies And Uses Thereof App 20110165622 - AN; LING-LING ; et al.	2011-07-07
High affinity antibodies against HMGB1 and methods of use thereof Grant 7,964,706 - Wu , et al. June 21, 2	2011-06-21
Humanized Anti-factor D Antibodies And Uses Thereof App 20110123528 - An; Ling-Ling ; et al.	2011-05-26
High Affinity Antibodies Against HMGB1 and Methods Of Use Thereof App 20100061987 - Wu; Herren ; et al.	2010-03-11
High affinity antibodies against HMGB1 and methods of use thereof Grant 7,585,504 - Wu , et al. September 8, 2	2009-09-08
High Affinity Antibodies Against Hmgb1 And Methods Of Use Thereof App 20090169546 - Wu; Herren ; et al.	2009-07-02
Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof App 20080311122 - Wu; Herren ; et al.	2008-12-18
Humanized Anti-Factor D Antibodies and Uses Thereof App 20080118506 - An; Ling-Ling ; et al.	2008-05-22
High affinity antibodies against HMGB1 and methods of use thereof App 20060099207 - Wu; Herren ; et al.	2006-05-11
Fce fusion proteins for treatment of allergy and asthma App 20040198961 - An, Ling-Ling ; et al.	2004-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.